Ironwood Pharmaceuticals
IRWD
Ironwood Pharmaceuticals (IRWD) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Citizens | Maintained | Market Outperform | $10.00 from $8.00 | Feb 26, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $5.00 from $3.00 | Jan 5, 2026 |
| Citizens | Upgraded | Market Perform → Market Outperform | $8.00 | Jan 5, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $3.00 from $1.00 | Nov 11, 2025 |
| Jefferies | Downgraded | Buy → Hold | $0.70 from $8.00 | Apr 15, 2025 |
| Wells Fargo | Downgraded | Overweight → Equal-Weight | $1.00 from $7.00 | Apr 15, 2025 |
| Leerink Partners | Maintained | Market Perform | $1.00 from $3.00 | Apr 14, 2025 |
| JMP Securities | Maintained | Market Outperform | $14.00 from $23.00 | Jan 30, 2025 |
| Craig-Hallum | Maintained | Buy | $8.00 from $10.00 | Jan 22, 2025 |
| Leerink Partners | Initiated Coverage | Market Perform | $5.00 | Sep 9, 2024 |
| Craig-Hallum | Maintained | Buy | $10.00 from $14.00 | Aug 9, 2024 |
| Wells Fargo | Maintained | Overweight | $12.00 from $14.00 | Aug 9, 2024 |
| Craig-Hallum | Maintained | Buy | $14.00 from $18.00 | May 10, 2024 |
| Wells Fargo | Maintained | Overweight | $14.00 from $20.00 | Mar 1, 2024 |
| Piper Sandler | Maintained | Overweight | $21.00 from $20.00 | Feb 16, 2024 |
| Craig-Hallum | Initiated Coverage | Buy | $21.00 | Jan 17, 2024 |
| Wells Fargo | Initiated Coverage | Overweight | $20.00 | Dec 14, 2023 |
| JMP Securities | Initiated Coverage | Market Outperform | $22.00 | Sep 28, 2023 |
| Piper Sandler | Maintained | Overweight | $19.00 from $16.00 | May 23, 2023 |
Frequently asked questions
What is the latest analyst rating on IRWD?
On Feb 26, 2026, Citizens maintained Ironwood Pharmaceuticals at Market Outperform with a price target of $10.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.